Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03257644
What this trial is testing

A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 70
Not applicableActive Not RecruitingNCT04206644
What this trial is testing

Systemic Sclerosis and Jak Inhibitors : Emphasis on Macrophages

Who this might be right for
Systemic Sclerosis
Rennes University Hospital 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT03610971
What this trial is testing

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

Who this might be right for
Chronic Phase Chronic Myeloid LeukemiaChronic Myeloid Leukemia, Chronic Phase
H. Lee Moffitt Cancer Center and Research Institute 24
Large-scale testing (Phase 3)Ended earlyNCT04377620
What this trial is testing

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

Who this might be right for
COVID-19
Incyte Corporation 211
Early research (Phase 1)Active Not RecruitingNCT04454658
What this trial is testing

Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis

Who this might be right for
Myelofibrosis (MF)
AbbVie 21
Testing effectiveness (Phase 2)Study completedNCT01795677
What this trial is testing

JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis

Who this might be right for
Myelofibrosis
French Innovative Leukemia Organisation 78
Large-scale testing (Phase 3)WithdrawnNCT05233410
What this trial is testing

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

Who this might be right for
Chronic Hand Eczema (CHE)
Incyte Corporation
Testing effectiveness (Phase 2)Looking for participantsNCT05088226
What this trial is testing

Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen

Who this might be right for
Peripheral Blood Stem Cell Transplantation
Chinese PLA General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT04397367
What this trial is testing

Low Dose Ruxolitinib in Combination With Methylprednisolone

Who this might be right for
aGVHDStem Cell Transplant Complications
Chinese PLA General Hospital 38
Large-scale testing (Phase 3)Study completedNCT00934544
What this trial is testing

Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial

Who this might be right for
Myelofibrosis
Novartis Pharmaceuticals 219
Not applicableStudy completedNCT06898372
What this trial is testing

Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières Syndrome

Who this might be right for
Aicardi-Goutières Syndrome (AGS)
IRCCS Fondazione Stella Maris 24
Testing effectiveness (Phase 2)Ended earlyNCT02091752
What this trial is testing

A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)

Who this might be right for
Primary Myelofibrosis
Novartis Pharmaceuticals 3
Testing effectiveness (Phase 2)Study completedNCT04374149
What this trial is testing

Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS

Who this might be right for
Cytokine Release SyndromeCOVID19
Prisma Health-Upstate 20
Testing effectiveness (Phase 2)Looking for participantsNCT06536166
What this trial is testing

Ruxolitinib Treatment in Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis, Sporadic
Assistance Publique - Hôpitaux de Paris 80
Testing effectiveness (Phase 2)Ended earlyNCT01790295
What this trial is testing

Ruxolitinib Prior to Transplant in Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisPost Polycythemia Vera MyelofibrosisPost Essential Thrombocythemia Myelofibrosis
John Mascarenhas 21
Testing effectiveness (Phase 2)Looking for participantsNCT06936566
What this trial is testing

MAGIC Ruxolitinib for aGVHD

Who this might be right for
Acute Graft-versus-host DiseaseAllogeneic Bone Marrow TransplantationAdverse Effects
John Levine 98
Large-scale testing (Phase 3)Active Not RecruitingNCT04562389
What this trial is testing

Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis

Who this might be right for
Myelofibrosis
Karyopharm Therapeutics Inc 353
Testing effectiveness (Phase 2)Study completedNCT04359290
What this trial is testing

Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS

Who this might be right for
ARDS, HumanCOVID
Philipps University Marburg 15
Not applicableStudy completedNCT04838704
What this trial is testing

Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft Versus Host Disease
Zhejiang University 215
Large-scale testing (Phase 3)Active Not RecruitingNCT04468984
What this trial is testing

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

Who this might be right for
Myelofibrosis (MF)
AbbVie 330
Next Page